AstraZeneca PLC (LON:AZN)
13,974
-38 (-0.27%)
At close: Nov 28, 2025
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
458.57K GBP
Profits / Employee
74.15K GBP
Market Cap
216.70B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
| Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
| Dec 31, 2022 | 83,500 | 400 | 0.48% |
| Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
| Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
AstraZeneca News
- 2 days ago - Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies - CNBC
- 4 days ago - AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows - Benzinga
- 4 days ago - AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows - Benzinga
- 5 days ago - AstraZeneca Shares Leap 9% as Pharma Giant Secures Breakthrough Cancer Drug Approval in UK Market - ABC Money
- 5 days ago - AstraZeneca (AZN) and Harbour BioMed Enhance Biotherapeutics Partnership - GuruFocus
- 5 days ago - Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology - PRNewsWire
- 7 days ago - AstraZeneca To Invest $2 Billion In Maryland Manufacturing Expansion - Nasdaq
- 7 days ago - AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer - CNBC